Which Weight Management Injection Suits You Better?
Get Wegovy vs Mounjaro: Understanding the Key Differences
When you're looking to get Wegovy or Mounjaro, understanding their distinct mechanisms is crucial for making an informed choice. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone, working primarily on appetite centres in the brain. Mounjaro, containing tirzepatide, takes a dual approach by targeting both GLP-1 and GIP receptors, potentially offering enhanced glucose control alongside appetite suppression. Both are prescription-only medicines requiring clinical assessment and ongoing medical supervision.
The dosing schedules also differ significantly when you get Wegovy versus Mounjaro treatment. Wegovy follows a 5-dose escalation from 0.25mg to 2.4mg maintenance over 17+ weeks, whilst Mounjaro progresses through 6 doses from 2.5mg to 15mg maximum. This difference in dose ranges reflects their distinct active compounds and receptor targeting mechanisms. Both require gradual dose increases to minimise gastrointestinal side effects and optimise tolerance.
Get Wegovy Pricing vs Mounjaro Cost Comparison
Understanding the investment required to get Wegovy versus Mounjaro helps with treatment planning decisions. Wegovy pricing at EverydayMeds starts at £79.99 for the 0.25mg starter dose, progressing to £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), and £209.99 for the 2.4mg maintenance dose. New customers benefit from discount code FIRST40 applied at checkout, whilst returning customers use DOSE25 for ongoing treatment. Our Getting Started bundles, such as the Intro Duo (0.25mg & 0.5mg) at £169.99, provide convenient multi-pen supplies.
Mounjaro pricing follows a different structure due to its distinct dosing requirements and longer treatment progression pathway. When comparing the total investment to get Wegovy versus Mounjaro over the first year, both medications represent significant commitments that require careful financial planning. Our pharmacy team can provide detailed cost projections for both options during your consultation, helping you understand the long-term investment alongside the clinical considerations that determine suitability.
Clinical Evidence: How to Get Wegovy vs Mounjaro Results
The clinical evidence supporting both options provides valuable insights for patients seeking to get Wegovy or Mounjaro treatment. In the STEP 1 trial, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks, compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The STEP programme demonstrated consistent efficacy across different patient populations, including those with type 2 diabetes.
Mounjaro's clinical programme showed impressive results in the SURMOUNT trials, though direct head-to-head comparisons aren't available due to different trial designs and patient populations. When you get Wegovy or consider Mounjaro, your prescriber will evaluate which clinical profile better matches your individual health circumstances, including any existing conditions, medication interactions, and treatment goals.
How Wegovy Works When You Get Treatment
Understanding Wegovy's mechanism helps patients appreciate how this prescription-only medicine supports weight management goals. Semaglutide works by mimicking GLP-1, a natural hormone released by your intestines after eating, which signals fullness to your brain and slows gastric emptying. This dual action reduces appetite whilst promoting satiety after smaller meals, potentially helping patients feel satisfied with reduced calorie intake. The medication also influences food reward pathways in the brain, which may reduce cravings for high-calorie foods. These effects work synergistically when combined with a reduced-calorie diet and increased physical activity, as required by the licensed indication. Results typically become noticeable during the dose escalation phase, with optimal effects often achieved at maintenance dosing.
Get Wegovy Ordering Process Through EverydayMeds
Our streamlined process makes it straightforward to get Wegovy or Mounjaro through our GPhC-registered online pharmacy (#9012878). The journey begins with a comprehensive 3-minute clinical assessment covering your medical history, current medications, weight management goals, and any contraindications that might affect treatment suitability. Following submission, our qualified prescribers review your information within 3 working days (or 24 hours with express service), ensuring thorough clinical oversight before approving any prescription-only medicine. Once approved, your medication is dispatched via next-day cold-chain delivery, maintaining the strict temperature requirements essential for these biological medications. Our pharmacy team remains available for ongoing support throughout your treatment journey, helping address any questions about administration, side effects, or dose progression.
Storage and Practical Considerations to Get Wegovy Success
Proper storage significantly impacts treatment success when you get Wegovy or Mounjaro prescriptions. Wegovy requires refrigeration at 2-8°C before first use but offers exceptional travel flexibility with 6 weeks room temperature storage below 30°C once removed from the fridge. This storage advantage makes Wegovy particularly suitable for frequent travellers or those with unpredictable schedules, compared to Mounjaro's 21-day room temperature limit. The FlexTouch pen device provides intuitive injection delivery, with clear dose escalation guidance from your prescriber. Each pen contains 4 weekly doses, and patients progress through the dose escalation schedule regardless of weight loss progress, as this gradual increase is designed to optimise tolerance and minimise side effects. Understanding these practical elements before you get Wegovy treatment ensures smooth integration into your daily routine.
Get Wegovy vs Mounjaro: Choosing Your Optimal Path
The decision to get Wegovy versus Mounjaro ultimately depends on individual clinical factors that your prescriber will evaluate during consultation. Wegovy's single GLP-1 mechanism may suit patients who prefer the established semaglutide profile, whilst Mounjaro's dual GLP-1/GIP approach might benefit those requiring enhanced glucose metabolism effects alongside weight management. Your medical history, including any diabetes, cardiovascular conditions, or previous weight management attempts, influences this clinical decision.
Both medications require identical lifestyle commitments—adherence to a reduced-calorie diet and increased physical activity—as mandated by their licensed indications. Neither represents a standalone solution, and success depends on comprehensive lifestyle modification alongside pharmaceutical support. EverydayMeds provides access to both options, allowing your prescriber to recommend the most suitable choice based on your individual circumstances rather than pharmacy limitations.
Complete Your Get Wegovy or Mounjaro Journey Today
Ready to get Wegovy or explore Mounjaro options through the UK's most comprehensive weight management pharmacy service? Our clinical team stands ready to guide you through the assessment process, ensuring you receive the most appropriate prescription-only medicine for your individual needs. New customers should apply discount code FIRST40 at checkout, whilst returning customers benefit from DOSE25 for continued treatment affordability. Visit our weight loss collection at https://everydaymeds.co.uk/collections/weight-loss to begin your clinical assessment today. With both Wegovy and Mounjaro available through our GPhC-registered pharmacy (#9012878), you can trust in comprehensive clinical oversight, cold-chain delivery, and ongoing support throughout your weight management journey. Your transformation begins with expert guidance, pharmaceutical excellence, and the convenience that makes sustainable weight management achievable.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
